Others titles
- Aspirin or Clopidogrel Treatment in the Management of Hip Fractures
- AAOS Guidelines on Hip Fracture Management
- Early Versus Delayed Drug Treatment for Hip Fractures
- Aspirin or Clopidogrel Side Early Versus Delayed Treatment in Elderly Hip Fractures
- Antiplatelet Drug Aspirin or Clopidogrel Early Versus Delayed Treatment in Elderly Hip Fractures
- Antiplatelet Therapy Aspirin or Clopidogrel Early Versus Delayed Treatment in Elderly Hip Fractures
Keywords
- Hip Fractures
- Aspirin or Clopidogrel Treatment
- Early Versus Delayed Treatment for Hip Fractures
- Treatment for Hip Fractures
- General Anesthesia for Hip Fractures in the Elderly
- Anesthesia for Hip Fractures
- Fractures in the Elderly
- Clopidogrel Side Effects
- Antiplatelet Drugs for Fracture
- Antiplatelet Therapy
Aspirin or Clopidogrel Early VS Delayed Treatment in Hip Fractures
This dataset showcases the limited evidence that supports not delaying hip fracture surgery for patients on aspirin and/or clopidogrel.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
Previously, some surgeons have delayed surgery for hip fracture patients on Aspirin and/or clopidogrel. This systematic review suggests at worse that there is no advantage to this practice or that in fact, the advantage is for patients where surgery is not delayed. The benefit of implementing this recommendation is preventing an unnecessary (unhelpful) delay in performing hip fracture surgery.
As with all surgical procedures, there are potential risks and complications, including, but not limited to, the possibility of bleeding. There is no data suggesting patient outcome harms will occur with the implementation of this recommendation.
About this Dataset
Data Info
Date Created | 2014-09-05 |
---|---|
Last Modified | 2014-09-05 |
Version | 2014-09-05 |
Update Frequency |
Never |
Temporal Coverage |
2003-2013 |
Spatial Coverage |
United States |
Source | John Snow Labs; American Academy of Orthopaedic Surgeons (AAOS); |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | Hip Fractures, Aspirin or Clopidogrel Treatment, Early Versus Delayed Treatment for Hip Fractures, Treatment for Hip Fractures, General Anesthesia for Hip Fractures in the Elderly, Anesthesia for Hip Fractures, Fractures in the Elderly, Clopidogrel Side Effects, Antiplatelet Drugs for Fracture, Antiplatelet Therapy |
Other Titles | Aspirin or Clopidogrel Treatment in the Management of Hip Fractures, AAOS Guidelines on Hip Fracture Management, Early Versus Delayed Drug Treatment for Hip Fractures, Aspirin or Clopidogrel Side Early Versus Delayed Treatment in Elderly Hip Fractures, Antiplatelet Drug Aspirin or Clopidogrel Early Versus Delayed Treatment in Elderly Hip Fractures, Antiplatelet Therapy Aspirin or Clopidogrel Early Versus Delayed Treatment in Elderly Hip Fractures |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
Study | Description of the previous studies used in this research. | string | required : 1 |
Outcome | Description of the reported outcomes from the participants who received Aspirin or Clopidogrel whether early or delayed treatment is used for the research study. | string | required : 1 |
Duration | Description of the duration of the effect of Aspirin or Clopidogrel whether early or delayed. | string | required : 1 |
Group_1 | Description of the treatment used in the first group. | string | required : 1 |
Group_2 | Description of the treatment used in the second group. | string | required : 1 |
Population_Size | Shows the number of participants or population size in a certain group that received Aspirin or Clopidogrel whether early or delayed. | integer | level : Ratiorequired : 1 |
Statistic | Description of the measurable characteristic of a sample population. | string | required : 1 |
Result | Results of the study. | number | level : Ratiorequired : 1 |
Probability | Effectiveness of the result based on the hypothesis of the study. | string | - |
Study_P_Value | Statistical significance of the results of the study. | string | - |
Favors | Description of which method is more effective. | string | required : 1 |
Data Preview
Study | Outcome | Duration | Group 1 | Group 2 | Population Size | Statistic | Result | Probability | Study P Value | Favors |
Chechik et al 2012 | Mortality, in hospital | Varied | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | % risk difference | -6.67 | 0.12 | NS | |
Chechik et al 2012 | Mortality, within 1st year | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | Risk ratio | 0.67 | 0.38 | NS | |
Chechik et al 2012 | Complication: ACS | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | Risk ratio | 3.0 | 0.33 | NS | |
Chechik et al 2012 | Complication: CVA | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | Risk ratio | 1.0 | 1.0 | NS | |
Chechik et al 2012 | Complication: Sepsis | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | Risk ratio | 0.67 | 0.64 | NS | |
Chechik et al 2012 | Complication: Pneumonia | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | Risk ratio | 2.0 | 0.4 | NS | |
Chechik et al 2012 | Complication: Pulmonary Oedema | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | % risk difference | -10.0 | 0.05 | NS | |
Chechik et al 2012 | Complication: PE | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | % risk difference | -3.33 | 0.27 | NS | |
Chechik et al 2012 | Complication: Decubitus ulcer | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | % risk difference | -3.33 | 0.27 | NS | |
Chechik et al 2012 | Complication: GI bleeding | 12 | Clopidogrel, early treatment | Clopidogrel, delayed treatment | 60 | % risk difference | -10.0 | 0.05 | NS |